Assyro AI
Back to Glossary
General

PART 211

21 CFR Part 211 specifies current good manufacturing practice requirements for finished pharmaceuticals.

Usage Examples

  • PART 211 improved consistency across global submission planning documents.
  • PART 211 was included in the cross-functional regulatory decision log.
  • Program teams used PART 211 to align regulatory, quality, and clinical milestones.

What is PART 211?

Part 211 establishes detailed requirements for quality control, laboratory operations, production controls, records, and complaint handling. It is a core framework for preventing batch failures, reducing warning letter risk, and supporting reliable release decisions.

Regulatory Context

This term appears most often in general workflows where submission quality, regulatory evidence, and audit readiness depend on consistent language. It is commonly referenced alongside 21 CFR 211.

FDAICHHealth Canada

When This Matters

  • PART 211 improved consistency across global submission planning documents.
  • PART 211 was included in the cross-functional regulatory decision log.
  • Program teams used PART 211 to align regulatory, quality, and clinical milestones.

Common Mistakes

  • Relying on generic terminology without mapping to the active jurisdiction context.
  • Skipping cross-links between terms, tools, and active regulatory references.
  • Failing to maintain a single source of truth for regulatory definitions internally.

Related Regulations

21 CFR 211

Frequently Asked Questions

PART 211 is a regulatory concept used to improve submission quality, compliance consistency, and decision traceability.

PART 211 improves consistency in decisions, documentation, and authority communication.

Weak execution of PART 211 often leads to avoidable deficiencies, rework, and slower authority review cycles.

Related Terms

Related Use Cases

Related Regulatory Intelligence

Related Actions

Sources & References

Agent CTA Background

Simplify PART 211 compliance